Chemistry and Biochemistry

PhD, University of Montana

Travis Denton's research interests include synthetic medicinal chemistry, neuroscience, drug metabolism and disposition, pharmacokinetics and carbohydrate and polymer chemistry. His research group is interested in developing small molecules to specifically target glutamatergic and acetylcholinergic receptors in the brain for the treatment of a variety of neurological diseases, addictions and pathologies including, but not limited to, Alzheimer's disease, nicotine addiction and stroke. He is working on developing carbohydrate-based, biodegradable, polymeric materials for a wide variety of applications including cell targeted, non-viral gene delivery agents, novel antibiotics and pseudostationary phases for electrokinetic chromatography.